Researchers at Houston Methodist have developed an artificial intelligence (AI) software that reliably interprets mammograms, assisting doctors with a quick and accurate prediction of breast cancer risk. According to a new study published in Cancer (early online Aug. 29), the computer software intuitively translates patient charts into diagnostic information at 30 times human speed and with 99 percent accuracy.
“This software intelligently reviews millions of records in a short amount of time, enabling us to determine breast cancer risk more efficiently using a patient’s mammogram. This has the potential to decrease unnecessary biopsies,” says Stephen T. Wong, Ph.D., P.E., chair of the Department of Systems Medicine and Bioengineering at Houston Methodist Research Institute.
The team led by Wong and Jenny C. Chang, M.D., director of the Houston Methodist Cancer Center used the AI software to evaluate mammograms and pathology reports of 500 breast cancer patients. The software scanned patient charts, collected diagnostic features and correlated mammogram findings with breast cancer subtype. Clinicians used results, like the expression of tumor proteins, to accurately predict each patient’s probability of breast cancer diagnosis.
In the United States, 12.1 million mammograms are performed annually, according to the Centers for Disease Control and Prevention (CDC). Fifty percent yield false positive results, according to the American Cancer Society (ACS), resulting in one in every two healthy women told they have cancer.
Currently, when mammograms fall into the suspicious category, a broad range of 3 to 95 percent cancer risk, patients are recommended for biopsies.
Over 1.6 million breast biopsies are performed annually nationwide, and about 20 percent are unnecessarily performed due to false-positive mammogram results of cancer free breasts, estimates the ACS.
The Houston Methodist team hopes this artificial intelligence software will help physicians better define the percent risk requiring a biopsy, equipping doctors with a tool to decrease unnecessary breast biopsies.
Manual review of 50 charts took two clinicians 50-70 hours. AI reviewed 500 charts in a few hours, saving over 500 physician hours.
“Accurate review of this many charts would be practically impossible without AI,” says Wong.
The Latest on: Breast cancer risk prediction
[google_news title=”” keyword=”breast cancer risk prediction” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Breast cancer risk prediction
- America's ticking cancer time bomb: 135,000 cases were missed during Covid as hospitals focused on viruson February 22, 2024 at 8:12 am
Researchers at the University of Kentucky made the startling prediction Experts warned patients would ... with patients with prostate, female breast and lung cancer most likely to have their illness ...
- Research identifies cancer risk patterns in families of men with fertility problemson February 22, 2024 at 7:27 am
This would enable doctors to make more accurate predictions of risk of cancer for men with ... akin to the way mutations in the BRCA gene increase the risk of breast cancer in families that carry this ...
- Study Finds Sisters of Women With High Breast Cancer Risk Share Common Factorson February 20, 2024 at 4:00 pm
The prospective study enrolled healthy women in the Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA) screening cohort from October 2010 to March 2013, linking them to their ...
- The Use of Genetics for Disease Prediction Improves for Ten Disorderson February 20, 2024 at 7:21 am
Polygenic risk scores for asthma, atrial fibrillation, breast cancer, chronic kidney disease, coronary heart disease, hypercholesterolemia, prostate cancer, type 1 diabetes, obesity, and type 2 ...
- Gene-Based Tests Could Predict Your Odds for Common Illnesseson February 20, 2024 at 3:47 am
Accurate genetic tests for 10 common diseases are nearly ready for everyday use in doctor’s offices, a new study says ...
- Lung cancer: Can experts predict which patients are at high risk of recurrence?on February 19, 2024 at 4:30 pm
Treatment for lung cancer patients is the same for everyone, regardless of the risk of recurrence. The use of a new technology combined with AI could refine the diagnosis. Lung cancer is responsible ...
- Lung cancer: Predicting which patients are at high risk of recurrence to improve outcomeson February 19, 2024 at 8:48 am
Lung cancer is responsible for more deaths than breast, colon and prostate cancer combined. With advancements in lung cancer screening, it is expected that more patients will be diagnosed at earlier ...
- More than 275 million never-before-seen gene variants uncovered in US populationon February 19, 2024 at 8:00 am
The newly uncovered gene variants were identified as part of an analysis of the DNA of more than 400,000 people in the U.S. who agreed to participate in the All of Us Research Program.
- Genetic risk prediction for ten chronic diseases moves closer to the clinicon February 19, 2024 at 8:00 am
By analyzing millions of small genetic differences across a person's genome, researchers can calculate a polygenic risk score to estimate someone's lifetime odds of developing a certain disease. Over ...
- 'Help is right here': Roswell Park brings lung cancer screening to people who need iton February 19, 2024 at 7:50 am
Roswell Park Comprehensive Cancer Center's mobile lung cancer screening unit, called EDDY (which stands for Early Detection Driven to You) is aimed at making lung cancer screening more accessible to ...
via Bing News